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Genomic aberrations recurrent in a particular cancer type can be important prognostic markers for tumor progression.
Typically in early tumorigenesis, cells incur a breakdown of the DNA replication machinery that results in an
accumulation of genomic aberrations in the form of duplications, deletions, translocations, and other genomic
alterations. Microarray methods allow for finer mapping of these aberrations than has previously been possible;
however, data processing and analysis methods have not taken full advantage of this higher resolution. Attention has
primarily been given to analysis on the single sample level, where multiple adjacent probes are necessarily used as
replicates for the local region containing their target sequences. However, regions of concordant aberration can be
short enough to be detected by only one, or very few, array elements. We describe a method called Multiple Sample
Analysis for assessing the significance of concordant genomic aberrations across multiple experiments that does not
require a-priori definition of aberration calls for each sample. If there are multiple samples, representing a class, then
by exploiting the replication across samples our method can detect concordant aberrations at much higher resolution
than can be derived from current single sample approaches. Additionally, this method provides a meaningful approach
to addressing population-based questions such as determining important regions for a cancer subtype of interest or
determining regions of copy number variation in a population. Multiple Sample Analysis also provides single sample
aberration calls in the locations of significant concordance, producing high resolution calls per sample, in concordant
regions. The approach is demonstrated on a dataset representing a challenging but important resource: breast tumors
that have been formalin-fixed, paraffin-embedded, archived, and subsequently UV-laser capture microdissected and
hybridized to two-channel BAC arrays using an amplification protocol. We demonstrate the accurate detection on
simulated data, and on real datasets involving known regions of aberration within subtypes of breast cancer at a
resolution consistent with that of the array. Similarly, we apply our method to previously published datasets, including
a 250K SNP array, and verify known results as well as detect novel regions of concordant aberration. The algorithm has
been fully implemented and tested and is freely available as a Java application at http://www.cbil.upenn.edu/MSA.
Citation: Guttman M, Mies C, Dudycz-Sulicz K, Diskin SJ, Baldwin DA, et al. (2007) Assessing the significance of conserved genomic aberrations using high resolution genomic
microarrays. PLoS Genet 3(8): e143. doi:10.1371/journal.pgen.0030143
Introduction
In cancer cells, aberrations can turn on or off various
pathways necessary for tumor development and survival [1].
Array comparative genomic hybridization (aCGH) is a highly
parallel microarray-based method for detecting DNA copy
number aberrations. aCGH detects genomic aberrations at a
higher resolution than previous methods including meta-
phase chromosome–based CGH ([2,3], reviewed in [4,5]), and
has proven to be a powerful tool for determining genomic
aberrations of interest in various cancer types [6–8].
Similarly, this technology is quickly becoming widely used
to characterize the genomic aberrations in various genetic
disorders ([9,10] reviewed in [11]).
The analysis of new high resolution CGH data has proven
challenging because most of the technical issues present in
microarray gene expression analysis are also present in
aCGH, as well as some new CGH-speciﬁc challenges. The
most fundamental problem is to transform raw microarray
data into the most accurate copy-number calls at the highest
resolution possible (see [12] for review). This is known as the
single sample problem, and there have been numerous
publications suggesting approaches to this problem, including
hidden Markov models [13], Circular Binary Segmentation
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methods is that they attempt to ﬁnd aberrant segments in the
genome by using neighboring probes as replicates to give
evidence of aberration at proximal locations.
Such single sample approaches can signiﬁcantly decrease
the native resolution of the array and result in a loss of
information because important aberrations can be short
enough to be detected by only one, or very few, array
elements. If only one array is being analyzed, or if one is
interested in the aberrations that are unique to a given
individual, then there is little choice but to use one of the
single sample methods. However, when the goal is to ﬁnd
concordant aberrations across a class of samples, we can take
a different approach. In the multiple sample case we can
perform statistical tests for concordant signal across samples,
for each array element individually. This allows multiple
(class-speciﬁc) samples to provide replication for each array
element individually, in order to control the error rates
statistically. In this way, resolution can be as ﬁne as the probe
spacing allows. This approach allows for leveraging multiple
samples to simultaneously increase the resolution and the
power of the analysis. To date, few methods have attempted
to address this multiple sample problem statistically [16–19].
Methodology
Considering one experiment at a time, it is difﬁcult to
determine effective parameters to make single sample calls,
because it is difﬁcult to distinguish signal from noise when
aberrations are small. Looking across multiple samples for
consistent effects it becomes clearer what is concordant
signal and what is noise. We will deﬁne concordant signal as
any aberration that occurs at a given location in more
samples than would be expected by chance, under a null
model, using some reasonable statistic.
In order to assess the signiﬁcance of concordant aberration
from a set of samples given single sample aberration calls, we
use a nonparametric approach based on the Signiﬁcance
Testing for Aberrant Copy number (STAC) algorithm [16,20],
which provides permutation based concordance p-values for
each location. A nonparametric approach is taken because
the true distributions involved in aCGH data are not known,
nor can they be reasonably estimated. Therefore, in order to
avoid making unrealistic assumptions about the data that
would be required in a generative model, we rely on standard
permutation approaches to obtain p-values to assess signiﬁ-
cance [21]. The null hypothesis is: given the rate of aberration
for each sample, the locations of the aberrations are
independent from sample to sample. To date, all multiple
sample statistical methods, including STAC, take as input a
set of aberrant intervals for each sample. However, we
generally do not know the single sample aberrations, or the
optimal criterion at which to determine aberration regions
for each sample. This introduces an element of arbitrariness
into a STAC analysis in that there are many ways to make the
single sample calls to prepare the input to STAC. Further-
more, it is not clear that there is an optimal criterion at which
to make single sample calls from microarray intensities, as
different structural aspects of the data and different levels of
noise are observable at different sensitivities (i.e., thresholds
that we use to make the calls), and any given one may miss
important information. This is demonstrated below on real
data. Multiple Sample Analysis (MSA) aims to capture as
much information as possible by measuring signiﬁcance
across a range of parameter values, and merging the
information, with attention to multiple-testing issues. This
allows us to gain power in the concordance analysis while
controlling the family-wise error rate (FWER) for multiple
locations. A ﬁnal aberration call is made for each sample, at
each location of signiﬁcant concordance, by using the
parameters that resulted in a signiﬁcant p-value at that
location. The parameter cutoff for making an aberration call
in the samples at a given location is therefore a function of
location because signal-to-noise ratio (SNR) varies at each
location, depending on the level of aberration, the hybrid-
ization afﬁnity of the probe, spatial effects of the array,
normalization, and other factors.
MSA provides high resolution mapping of aberrant regions
and provides a statistically meaningful method of integration
between experiments. MSA is not just a substitute at low
resolution for the single sample approaches; it is a different
way of approaching the problem, a way that can give more
powerful information about the experiments and the samples
of interest.
Results
Aberration Calls
There are several natural criteria by which to quantify the
raw signal from an individual array element into an
aberration call at that location. The simplest is a straightfor-
ward threshold cutoff for the sample/normal signal ratio. If
the data were perfect then the cutoff of Test
Reference   1
2 for loss
and Test
Reference   3
2 for gain would be sufﬁcient. In practice, any
criterion will offer a trade-off between true and false signal. If
the null distribution of these ratios varies signiﬁcantly from
array element to array element, then a single cutoff can be
conservative for some elements and liberal for others.
Many effects can introduce bias that will be difﬁcult to
distinguish from biological signal unless it is controlled for in
the experimental design. Bias of two types can occur, across
sample bias and within sample bias. Across sample bias can
occur due to probe-speciﬁc hybridization, sequence bias,
PLoS Genetics | www.plosgenetics.org August 2007 | Volume 3 | Issue 8 | e143 1465
Determining Conserved Genomic Aberrations
Author Summary
Cancer is a genetic disease caused by genomic mutations that
confer an increased ability to proliferate and survive in a specific
environment. It is now known that many regions of genomic DNA
are deleted or amplified in specific cancer types. These aberrations
are believed to occur randomly in the genome. If these aberrations
overlap more than would be expected by chance across individual
occurrences of the cancer this suggests a selective pressure on this
aberration. These conserved aberrations likely represent regions that
are important for the development, progression, and survival of a
specific cancer type in its environment. We present a method for
identifying these conserved aberrations within a class of samples.
The applications for this method include accurate high resolution
mapping of aberrations characteristic of cancer subtypes as well as
other genetic diseases and determination of conserved copy
number variations in the population. With the use of high resolution
microarray methods we have profiled different tumor types. We
have been able to create high resolution profiles of conserved
aberrations in specific cancer types. These conserved aberrations are
prime targets for cancer therapies and many of these regions have
already been used to develop effective cancer therapeutics.ampliﬁcation bias, or many other probe-speciﬁc factors. In
this case there will be a nonrandom distribution of observed
‘‘aberrations’’ when in fact there is no biological aberration.
Within-sample bias can occur when contiguous regions on
the chromosome are dependent for reasons other than
biology, such as ampliﬁcation bias causing contiguous regions
to be over or under ampliﬁed. These aberrations have been
noted before and were termed ‘‘local trends’’ by Olshen et al.
[14]. We have similarly observed this effect when we employ
an ampliﬁcation protocol prior to hybridization. While our
method would not be affected by within-sample bias, because
it will be seen as noise in the null model, it will be affected by
concordant bias, as would any multiple sample method. To
address this issue, it might be necessary to perform a number
of normal/normal hybridizations to estimate the normal/
normal distributions individually for each array element. We
deﬁne a normal/normal distribution as a distribution of
normal cells hybridized and processed similarly to the real
data. The criterion for each array element can then be based
on the distribution for that element alone—for example, the
standard deviation for each probe can be used as a cutoff for
its corresponding element. We note that this effect can not be
controlled for computationally due to the contiguous and
concordant nature of many of these aberrations.
In all cases, we assume we have a criterion that is based on
some kind of cutoff, and we are interested in assessing
concordant signal across multiple samples based on varying
this cutoff appropriately. Even when using a single sample
approach such as CBS, one needs to deﬁne a cutoff parameter
to determine ampliﬁcation and deletion of regions of
aberration. This step will be described more precisely below.
For any ﬁxed cutoff we test for signiﬁcance by using the
STAC algorithm [16], which provides permutation-based
concordance p-values for each location, which are multiple
testing corrected to control the FWER for the multiple
locations being tested [21].
STAC Algorithm
Given aberration regions in multiple samples, STAC
deﬁnes two statistics to measure concordance, the ‘‘fre-
quency’’ and the ‘‘footprint’’ [16]. For each statistic and each
location a multiple testing corrected permutation p-value is
computed, as described below. The frequency statistic
measures the percent of samples with a given aberration at
a given position. The footprint statistic measures tightness of
alignment of a set of aberrant intervals that cover a given
location, and is more sensitive than the frequency in most
cases.
There are a few important aspects of the STAC algorithm
that we take advantage of in our method. First, STAC
provides p-values for concordance of aberration at each
position. Second, the STAC p-values are multiple testing
corrected across genomic positions to control the FWER.
Third, the STAC footprint p-value takes into account the size
of the region of aberration as well as the overall rate of
aberration in the genome.
Permuting the Data
The permutation scheme moves each interval of aberration
in each sample to a random location. Entire intervals are
moved without breaking or resizing them in order to
maintain the dependency between neighboring aberrant
sites, while perturbing any alignment between samples. The
goal of the permutation scheme is to maintain as much of the
structure as possible in each sample while disrupting align-
ment between samples. An example of data and its sample
permutations is shown schematically in Figure 1C.
Frequency Statistic
The frequency (Yu) is the number of intervals that overlap a
particular location u, where u ¼ 1 . . .L, length of genome.
Rather than drawing a threshold cutoff for making calls,
which does not take into account the background rate of
aberration or control the false-positive rate, a permutation
test is performed. Given a permutation of the data, we
calculate M ¼ maxu¼1;2;:::;L Yu.Ap-value is then obtained by
comparing each observed Yu to the distribution of M (Figure
2). Since the distribution is of the maximum frequency over
all locations, the p-value is multiple testing corrected.
The frequency can fail to detect important regions of
concordance within datasets because it fails to exploit the
structure of the data and the intervals overlapping a location.
For example, in Figure 1A, Region 1 and Region 2 have the
same frequency but the frequency statistic will fail to detect
any difference between them. In reality, the concordance of
arrangement A suggests that true aberrations are more likely
occurring at that location compared to arrangement B.
Figure 3 illustrates in real data a location where the frequency
is not signiﬁcant in the permutation model but the alignment
of the intervals suggests a real aberration. The footprint
statistic is more sensitive to these effects.
Footprint Statistic
A stack is deﬁned as a set of intervals that lie over the same
location. The location is called an ‘‘anchor point’’ of the
stack. A stack contains at most one interval from each sample;
however, it need not contain all intervals over a given
location. If a stack has n intervals we refer to it as an n-stack.
The footprint is deﬁned for each stack and measures the
length of the projection of a given stack onto the genome
(Figure 1A). Any given stack contains many substacks. For
example, a stack of four intervals contains four 3-stacks and
six 2-stacks (Figure 1B).
To make the footprint comparable among stacks involving
intervals of differing widths, it is normalized by the expected
footprint: NF ¼ F
EF, where EF is the expected value of the
footprint under the permutation model. This eliminates the
bias that shorter intervals tend to have smaller footprints. In
other words, stacks that are more tightly aligned tend to have
smaller normalized footprints regardless of the lengths of the
intervals involved in the stacks.
Additionally, long intervals can obscure the alignment of a
stack over a location (Figure 1B). Therefore, in order to assess
the signiﬁcance of the footprint at a given location we look
for tightly aligned substacks of the stack of all intervals
anchored at the location. To assess signiﬁcance, we perform a
subset search to identify the minimum normalized footprint
of all substacks over a given genomic location.
For a ﬁxed stack S a p-value is assessed as follows. For each
permutation of the data the smallest normalized footprint is
determined over all stacks that have the same number of
intervals as the stack in question. This provides a permutation
p-value for the stack. A footprint-based ‘‘score’’ for a given
location is then taken to be the minimum p-value of all stacks
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Determining Conserved Genomic Aberrationsanchored at the location. The scores themselves cannot be
taken as p-values because they are the minimum of many p-
values. The signiﬁcance level of each score is instead assessed
via a second round of permutations, analogously to how the
frequency p-values are assessed.
The quantities involved cannot typically be computed
exactly because of the large number of possible substacks in
the genome (ﬁgure 1B). Therefore, the minimum normalized
footprint over each location is heuristically approximated.
Subset Search and Run Time
In our implementation we use the algorithm as described
in Grant et al. [20] and Diskin et al. [16]. However, we employ
a modiﬁed search strategy that allows for a much faster
approximation of the minimum normalized footprint over all
possible subsets in the aberrant proﬁles.
STAC, as described by Diskin et al., runs at O(M
4L
3) per
permutation, where M is the number of samples and L is the
number of locations in the genomic region being analyzed.
This runtime is further affected by the constant B, which
represents the search parameter introduced by Grant et al.
and subsequently used by Diskin et al., B can only be regarded
as a constant if the value of B is constant for all analyses. In
reality, B must be signiﬁcantly larger than L to ensure all
positions are represented at least once in the smallest B
stacks. Furthermore, the choice of B can change the results of
the analysis signiﬁcantly. As discussed in Diskin et al., as the
parameter is raised, the global minimum is approached;
however, the computational complexity increases rapidly
with the size of B. Therefore, we would want to make sure that
B is chosen as to make computation as accurate and efﬁcient
as possible.
Our implementation differs from the original STAC
algorithm in that the search phase is performed at each
location separately which effectively reduces the search
parameter to one. This reduces the computational complex-
ity from O(M
4L
4)t oO ( M
2L
2) and eliminates the search
parameter by changing the heuristic search algorithm for
determining the minimum normalized footprint. At each
anchor point a we estimate the smallest normalized footprint
for stacks of size 2, 3, ..., M by taking the smallest normalized
footprint for step k and extending it into all possible k þ 1
stacks anchored at the same location, and taking the one with
the smallest normalized footprint. For each possible anchor
point we have an array of minimum normalized footprints
for 2, 3, ..., N. We do this for all anchor points, which is at
most L, the size of the genome, and take the global minimum
to obtain the distributions used as in Diskin et al. [16].
Extensive testing against the original algorithm showed very
little difference in reported p-values; however, the new
method is signiﬁcantly faster. A plot of actual computing
time as a function of the length of the genome and the
number of samples is shown in Figure 4. The optimized
version, STAC 1.2, is available for download and the new
search method is described in detail in the technical
speciﬁcations.
Data Processing
There are several considerations to make in practice. Some
arrays have tighter distributions across all elements and as
such require more liberal cutoffs to achieve the same amount
of signal compared with other arrays that have broader
distributions. To take this effect into account we have
implemented scale normalization [22] to normalize between
arrays. To the extent that this normalization causes us to be
too liberal on some samples, it will not result in concordant
false positives across multiple samples, so long as the noise is
distributed in each sample independently. This is expected if
concordant bias is properly controlled for, as discussed
above. Regardless of what statistical methods are used to test
for concordance, any concordant bias must be controlled for
at the level of the experiment design.
Selection of Cutoff Values
The sensitivity and speciﬁcity of any given cutoff depends
on the rate of aberration of the unit of analysis, e.g., the
entire genome, a single chromosome, or a chromosome arm.
In most cases, we expect the rate of aberration to be different
between different chromosome arms, because this has been
observed across a wide variety of tumor types. In this case, the
sensitivity of the analysis will be higher when performed
separately on these units. In the examples provided, the
typical unit of analysis is the chromosome arm. In other
speciﬁc cases there might be some other, smaller, unit that
may be appropriate.
We assume a ﬁxed set of samples is under consideration.
Assume there is some ﬁxed threshold parameter C, which
gives a ﬁxed set of location calls. To ﬁx ideas we could have a
number N of breast cancer hybridizations and C could simply
be a cutoff for red to green (normalized) intensity log ratio.
Alternatively, we might estimate null distributions for each
probe c, possibly with a battery of normal/normal hybrid-
izations, and take the cutoffs as Yc.  Xc þ kSDðXcÞ, for gain and
Yc ,   Xc   mSDðXcÞ for loss, for some choices of k and m. Yc is
the log ratio value for probe c and   Xc is the average value for
probe c and SD(Xc) is the standard deviation of probe c over
the set of normal/normal hybridizations. We allow k 6¼ m due
to the potential lack of symmetry between gains and losses.
While our implementation only contains a limited number of
methods for making calls by probes, a user can apply our
algorithm using any such method.
A conservative value of the cutoff C is calculated at which
there are relatively few calls being made for that value of C,
Figure 1. Illustration of Key Terms Used in the Description of the Analytical Method
(A) The footprint is defined for a given stack as the vertical projection on the genome of all overlapping intervals. The footprint measures the tightness
of the overlapping intervals within a given stack. The frequency measures the number of overlapping intervals over a given location. These two metrics
are sensitive to different effects, as a region can have the same frequency but different footprints, such as Region 1 and Region 2, which share a
frequency but have different footprints.
(B) A stack contains substacks of sizes 2, ..., k (the number of intervals in a given stack). An example of a stack and its most significant substack of size
three is shown.
(C) Sample permutations are illustrated on data where little is aberrant to data where most of the genome is aberrant. A given interval is permuted by
randomly placing an interval in the genome rather than breaking up the positions within an interval. Each sample is permuted independently.
doi:10.1371/journal.pgen.0030143.g001
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Determining Conserved Genomic Aberrationsdenote this value by Cmax (Figure 5). STAC is then executed
on the data obtained by making calls using each of the values:
0;
Cmax
nt   1
;
2Cmax
nt   1
;
3Cmax
nt   1
;:::;Cmax
  
The lower the value of the threshold, the more signal and
noise is involved. In our implementation, the minimum value
of nt is 3, and the default value is 9. At each step we execute
STAC to obtain concordance p-values. We subsequently
perform a Bonferroni type correction, where we correct
Figure 2. Calculating p-Values from Raw Data
This figure illustrates how p-values are computed for the frequency statistic and the footprint statistic. The example tracks the frequency score but the
argument is analogous for the footprint. We first begin with the raw data and calculate a score for each position. We then permute the data computing
a maximum score for each permutation. We repeat the permutations n times, generating a distribution of the maximum observed score for each
permutation. We then compare the score for each position on the genome to the distribution of the maximum score to compute multiple testing
corrected p-values for each location.
doi:10.1371/journal.pgen.0030143.g002
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Determining Conserved Genomic Aberrationssome values higher than 1/nt, and some values lower (details
given in the next section). The corrected p-values are then
reported.
If every position is aberrant then no region will be
signiﬁcant. Therefore, at our most liberal value we are
allowing excessive noise and so do not expect to detect much
signal. However, if there were a strong concordance of a very
weak signal we would still detect it at this level. The beneﬁt of
sampling over various values is that the tight concordance
that can be found at the most liberal value may not be found
at more conservative values and vice versa (Figure 6).
We explored the possibility of ﬁnding an optimal single
value of C that maximizes the signal to noise in some overall
sense, however we found that information is generally lost
whenever a single value of C is used. This method instead
provides a way of optimizing the value of C for each position
of the genome independently.
Assessment of Concordant Aberration
We describe a correction scheme that corrects the nt tests
differently. This is done to balance the beneﬁcial effect of
performing tests with more cutoffs, against the detrimental
effect of having to make too strong a Bonferroni correction.
By prioritizing the regions we can mitigate the conservative-
ness of the Bonferroni correction at certain test values.
Since we are performing nt tests for each probe, we must
perform a multiple testing correction. We use a modiﬁed
Bonferroni correction, which requires nt to be of the form 2
k
Figure 3. Illustrates How the Footprint Can Identify Regions That the Frequency Misses
The starred region has a frequency that occurs under the permutation model frequently (frequency p¼1), yet the structure suggests a true aberration is
present. The footprint statistic identifies this aberration as significant. This also illustrates the dependency between the footprint and frequency.
Regions identified by the frequency are also identified by the footprint plus additional regions. The blue area tracks –log(p) for the frequency. The green
area tracks –log(p) for the footprint. The gray dotted lines indicate different significance levels.
doi:10.1371/journal.pgen.0030143.g003
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Determining Conserved Genomic Aberrationsþ1 for some k. The correction factor is based on bisecting the
interval [0,Cmax] k times with varying correction factors. We
then multiply the permutation p-values of each step by the
appropriate correction factor. Speciﬁcally, we multiply those
values of C that are introduced in the ith bisection by 2
i   1.
This gives n ‘‘adjusted’’ p-values p1,..., pn.. Let p*¼min(p1,...,
pn). If there is no aberration at the location, then the
unadjusted p-values are uniformly distributed and
Pp   ,
a
k þ 2
  
,Pp 1 ,
a
k þ 2
  
þ ::: þ Pp n ,
a
k þ 2
  
¼ 2
a
k þ 2
þ
X k 1
i¼0
2i a
2iðk þ 2Þ
¼ a
Therefore, if p    ac ¼ a
kþ2,o rp9 ¼ p ðk þ 2Þ a, we reject
the hypothesis that the concordance at the region is due to
chance with Type I error rate a. All MSA reported p-values
are these corrected p-values, so as to facilitate comparison to
a standard a level directly. We will refer to the multiple
testing corrected p-value, denoted p9,a sp for the remainder
of the manuscript.
The varying correction factors allow us more power than a
Bonferroni on our three most representative tests. This is
done because we expect that any strong signal not present in
any of the other values could still be signiﬁcant following
adjustment.
The power of this approach depends on an appropriate
number of permutations being used in the analyses. If one
uses only 100 permutations, then the minimum possible
uncorrected p-value will be approximately 0.01 and if only
three tests are used the minimum possible corrected p-value
is approximately 0.03. Therefore, it is important to ensure a
suitable permutation distribution based on the number of
tests to be used.
Making Single Sample Calls Using Multiple Sample
Significances
The method described above reports regions and con-
ﬁdences measuring signiﬁcant concordance. However, there
is still a need to make single sample calls in order to test such
questions as association between types and determination of
subtypes, clustering, and other downstream analytical tests, as
well as for visualization purposes. Since we are interested in
conserved effects we determine the single sample calls using
the information provided from multiple samples. By using
the different cutoff for each region given by the cutoff that
maximizes the concordance conﬁdence, we determine the
tightest multiple sample concordance for that region. These
highest conﬁdence calls are interesting because they mini-
mize the probability of making a false single sample call while
using the information from multiple samples to ﬁnely resolve
single sample calls. This gives a view of the data that has all
noise and nonconcordant signal removed, revealing just the
concordant signal. The single sample calls work well in
determining known aberrations and differences between
samples, as is seen in the examples below.
Examples
Formalin ﬁxed parafﬁn embedded samples. We examined a
set of human breast cancers that were laser-microdissected
from archived formalin ﬁxed parafﬁn embedded (FFPE)
tissue. These samples represent an important resource;
however, they also represent a challenging aCGH application,
as they tend to have signiﬁcant amounts of noise. Because
archived FFPE cancers and other tissues represent a vast and
rich research resource, an accurate and robust analytic
approach to proﬁling them is extremely valuable. Our goal
was to use known aberrations within these samples as a
benchmark for determining the ability to differentiate
between sample noise and real signal.
In order to differentiate between aberrations due to the
processing steps, we hybridized a set of normal–normal
samples where in one channel we laser microdissected normal
cells from FFPE tissue processed identically to our cancer
cells. The other channel was hybridized with a universal
reference from a pool of genomic DNA samples. The test
samples consisted of 20 ductal carcinoma in situ (DCIS) and
23 lobular carcinoma in situ (LCIS) microdissected samples,
hybridized with the same universal reference pool as the
normal controls.
DCIS. We ran our algorithm on the 20 DCIS samples to
generate conﬁdence values for each region. This resulted in
many known regions of aberration as well as other,
uncharacterized regions. One known small region of ampli-
Figure 4. Run Time of the STAC Algorithm
The time needed to run the STAC algorithm based on the original
implementation and our new implementation. (A) Plots the run time as
the length of the genome increases. (B) Plots the run time as the number
of samples is increased. The numbers do not represent a typical dataset
but rather a situation where every profile contains many aberrant
intervals. For most real datasets the run time is significantly faster.
doi:10.1371/journal.pgen.0030143.g004
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Determining Conserved Genomic Aberrationsﬁcation is on Chromosome 17q12, which involves the ERBB2
oncogene [23], aberrant expression of which is believed to
occur due to genomic ampliﬁcation of this region [7]. This is a
small highly concordant ampliﬁcation, usually limited to a
region of 1–2 Mb, an area covered by only one or two probes
on this array. MSA is able to identify the ampliﬁcation (p ¼
0.0069) over this small region (Figure 7A). Furthermore, we
were able to identify the single sample values at which this
aberration occurs. We veriﬁed this ampliﬁcation using
immunohistochemistry staining, which conﬁrmed the ampli-
ﬁcation in these samples.
For comparison we also utilized two single sample methods,
ChARM [24] and CBS (DNAcopy) [14]. We found that on some
arrays ERBB2 aberration was detected and on others it was
not. However, the samples with detected 17q12 ampliﬁcation
did not localize the affected region to 1–2 Mb but rather
indicated a much larger span that covered most of the
chromosome (Figure S1). This example is indicative of the
small but important regions that can be missed or mischar-
acterized by single sample approaches. While the ampliﬁca-
tion of this region may look like noise in one sample, when we
look across multiple samples and ﬁnd tight concordance we
are able to identify it.
We next compared Chromosome 8 aberrations between
our method and the single sample methods mentioned above.
In DCIS and invasive ductal carcinoma, Chromosome 8 has
been shown to contain a large deletion on the 8p arm and
many gains on the 8q arm [3,6,7,23]. MSA identiﬁes many
positions on the 8p arms that are, in fact, deleted and is able
to detect differences in deletion frequencies for speciﬁc
regions on the arm (Figure 7B). Rather than characterizing
the entire arm as deleted, MSA identiﬁes more precise
regions of deletion that are signiﬁcantly concordant across
the samples. In some of these samples, the single sample
methods could not pick up the deletion and in others, where
a deletion was detected, it was represented as loss of most of
the arm (Figure 8). We also found deletions on the q-arm, as
well as localized ampliﬁcations. Finally, we were able to
characterize the 2-Mb ampliﬁcation corresponding to MYC
ampliﬁcation (p ¼ 0.027) in 14/20 samples (Figure 7B).
MSA revealed a 2-Mb deletion on the 8q arm (p¼0.0028) as
well as other smaller 1-Mb regions (p ¼ 0.044–0.0028) of
deletion that were previously uncharacterized. Recently, a
study examining Chromosome 8 in invasive ductal carcinoma
cell lines using high resolution Chromosome 8–speciﬁc tiling
arrays was able to detect these same regions of deletion on
the 8q arm [25]. Our analysis detected these effects even
though some of them are represented by only a single array
element. This demonstrates the ability of MSA to map regions
at the native resolution of the array. A frequency plot of all of
the DCIS signiﬁcant concordant aberrations are presented in
Figure S2).
LCIS. We analyzed 23 cases of LCIS, another subtype of in
situ mammary carcinoma, and found 733 regions of aberra-
tion. Some of these regions correspond to known aberration
patterns, such as the loss of CDH1 on Chromosome 16q22.1,
that are believed to be characteristic of LCIS. In fact, many
pathologists use this as a discriminating marker between LCIS
and DCIS [6,23,26]. In addition to localizing the deletion of
CDH1 (p9 ¼ 0.0028), we were able to identify many high-
Figure 5. Example of the Multiple Sampling Approach on Neuroblastoma Chromosome 2 Data
(A) The distribution of aberrations is plotted versus the threshold cutoff of the log ratio for each sample. The red plot represents the percent aberration
of loss, green is gain, and blue is the total percent aberration at a cutoff.
(B) An image of the gains and losses called at three cutoffs is shown along with the log ratio used to determine gain and loss calls and the average
percent aberration at that cutoff.
doi:10.1371/journal.pgen.0030143.g005
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Determining Conserved Genomic Aberrationsconﬁdence deletions in the 16q arm (Figure S3) [27].
Chromosome 16q loss has been well-characterized within
LCIS using metaphase-based CGH analysis [3,23,26]. We also
identiﬁed many losses on Chromosome 16p, another charac-
terized aberration from metaphase based CGH studies
(Figure S3) [28,29]. A frequency plot of all of the LCIS
signiﬁcant concordant aberrations are presented in Figure
S4.
SNP data results. We have also tested our method on a set
of publicly available T cell lineage acute lymphoblastic
leukemia (T-ALL) samples [30]. This set contained 50 samples
proﬁled on the Affymetrix 250K SNP array [30]. We
performed this analysis to show that our algorithm works
well on higher resolution arrays. Running in parallel with 22
nodes (one for each chromosome), the entire analysis took
less than 48 h to complete. We were able to identify known,
veriﬁed regions of aberration in this data as well as additional
uncharacterized aberrations. A p-value plot is presented in
Figure S6.
Comparison to STAC Results
We applied MSA to a publicly available neuroblastoma
dataset generated by Mosse et al. [31]. This data was
previously analyzed using STAC based on a single processing
into aberration calls [16]. We analyzed this data using nine
tests each with 2,000 permutations. MSA found 747 signiﬁ-
cant regions (p , 0.05) (Table S1). In order to accurately
compare the results of Diskin et al. to the MSA results, we ran
STAC on the data using 2,000 permutations and applied our
extension scheme and data processing steps. We selected
ratio cutoffs used by Diskin et al., where a clone was called
gain if the ratio exceeded 1.2 and loss if the ratio was less than
0.8. We executed STAC at this cutoff and compared the
results to the MSA generated signiﬁcance values. MSA was
able to characterize 486 regions that STAC alone failed to
detect. The single STAC run was able to detect 87 regions that
MSA missed, and there were 261 regions found by both
analyses (Table S2).
Chromosome 2 represented a large number of the novel
regions and we therefore decided to look at the cutoff values
at which MSA determined these conﬁdence values. The
complete MSA conﬁdence view on Chromosome 2 is plotted
(Figure 9A), along with ﬁve of the MSA values (Figure 9B).
There are particular values of the cutoff at which regions of
tight concordance occur across the multiple neuroblastoma
samples, and this concordance is no longer present at many
other cutoffs. In fact, the two chromosome arms have quite
different aberration patterns and limiting the analysis to one
value will almost certainly lose information for one of the
arms of Chromosome 2, despite their separate analysis.
Therefore, by varying our cutoff and independently testing
each chromosome arm (as the unit of analysis), we can detect
many regions of tight concordance and high conﬁdence. A
frequency plot of all of the signiﬁcant neuroblastoma
aberrations are presented in Figure S5.
Merging Single Sample Approaches into MSA
As an alternative to the strategy that makes calls at the level
of the single array element, we also incorporated the CBS [14]
algorithm into the MSA scheme, using CBS to determine the
single sample calls and then calculating the MSA conﬁdences
for each region. A segment, based on the CBS algorithm, is a
region that is signiﬁcantly different from its neighboring
regions [14]. Each segment has an associated segment mean
(  S) that represents the average value of the probes within that
segment. However, segments alone are not biologically
meaningful, since it is possible to have a signiﬁcant segment
where the segment average is less than the cutoff value for a
one-copy ampliﬁcation,   S,log2ð3
2Þ¼0:585 = .T h e r ea r e
many possible ways to determine aberrations from the
segmentation data. One is to use threshold cutoffs, similar
to those discussed earlier. For example, a segment will be
called ampliﬁed if   S.Cg and a segment will be called lost if
  S,Cl. As before, it is difﬁcult to deﬁne a single Cg and Cl for
all regions assayed. Furthermore, there is an additional
complication in using a segmentation scheme since we must
also decide on a value for the segmentation parameter a.I fw e
decide on a ¼ 0.01 (the default value), we will detect very few
segments; however, if we increase the value of a we will detect
more segments until, if we set a ¼ 1, we will pick up almost
every element as an individual segment. Therefore, we need
to adjust both the value of a as well as the value of the
threshold parameter for determining aberration.
We found that as we modify the threshold values for which
we make calls we are able to characterize gross level
aberration, but the ﬁner-level aberrations are not detected.
This loss of resolution was expected due to the loss of
resolution within a single array that occurs due to segmenta-
tion. We tested this method on the data of Mosse et al. [31]
and the results are shown in Figure 10A. We also varied the
value of a to show the relative performance of our method
using more liberal single sample values for the segmentation.
The results are shown on the Naylor et al. [32] data using
Chromosome 17 as an example (Figure 10B). We similarly
applied a single sample method to the T cell leukemia 250K
SNP array and then ran MSA; the results are shown in Figure
S7.
MSA can be applied to segmented data to assess the
signiﬁcance of aberrations across multiple samples. Since
most single sample methods produce continuous ratio data
for segments, MSA can ﬁnd meaningful aberrations that
might not be found using a ﬁxed threshold. However,
performing segmentation can reduce the resolution of the
aberrations and eliminate concordance across samples. While
we still pick up many of the same aberrations when running
MSA on segmented data, the resolution is grosser than the
known aberration interval (Figure 10A). Additionally, there
Figure 6. STAC Confidences for the Three Most Extreme MSA Test Values
This illustrates, on real data, that one cutoff value that reveals signal in one region can obscure real signal in other regions.
(A) At a high cutoff it is possible to find tight concordance across positions 117–119 Mb and 190–191 Mb.
(B) A middle cutoff preserves tight concordance at 117–119 Mb but loses 190–191 Mb and picks up additional regions such as 175–180 Mb.
(C) At the lowest cutoff, the aberration at positions 117–119 Mb and at 175–180 Mb are obscured by noise. However, a new region at 181–184 Mb is
detected. The height of the bar corresponds to the confidence level (1   p). Dark gray bars are significant with p , 0.05.
doi:10.1371/journal.pgen.0030143.g006
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samples but have lower amplitudes or small widths, which
will prevent them from being detected by single sample
methods. If these aberrations are seen across multiple
samples, MSA can assign signiﬁcance to those regions that
might not be present post-segmentation. We ﬁnd that there
are many high-conﬁdence regions that are detected by MSA
in the T-ALL data that are missed when run post-segmenta-
tion.
Simulations
Multiple sample copy number aberration data simulator.
We generated random datasets with known parameters to test
the accuracy and speciﬁcity of the MSA algorithm. By
adjusting these parameters, we tested the effects of noise
and nonconcordant signal in the data on the ability of MSA to
detect concordant aberrations. The model is necessarily
simpler than real data; in particular, copy number and width
of aberrations are ﬁxed and the noise is constant across the
entire genome. However, the model is sufﬁcient to system-
atically test how the power of MSA decreases as noise and
aberrant signal is increased.
We use the single sample simulator as deﬁned, as in Olshen
et al. [14] and Lai et al. [12], where each position’s simulated
log ratio is given by Xi ¼ li þ e for 1   I   G, where e ; N(0,
r
2), li ¼ cIfl , I , l þ kg, G is the genome length, I is an
indicator random variable, c is the log of the copy number of
the aberrations, l is the location of the aberration, and k is the
width of the aberration [14]. The technical noise is controlled
by the parameter r
2.
To extend this simulator to model multiple sample
concordance, we introduce additional parameters. We
determine a number of samples (n) over which to test and
then pick locations where concordant aberrations will be
placed. We then specify the underlying frequency of aberra-
tion across the multiple samples for each location of
concordant aberration. Finally, we specify the underlying
copy number of the concordant aberrations at each location.
After the underlying state is determined, we specify regions
of nonconcordant aberration. We model aberrations that,
while biologically real, are random from sample to sample
and therefore should not contribute to multiple sample
concordance. We randomly pick locations, widths, and copy
number of nonconcordant intervals and they are generated
using the single sample model. An illustration of the
simulation method is shown in Figure 11A.
The number of nonconcordant intervals for sample k,
denoted Rk, is determined by Rk ; Poisson(k). The width of the
Figure 7. Concordant Aberrations on Chromosomes 8 and 17 in DCIS
(A) Copy number change for DCIS samples. No change (grey), deletion
(red), or gain (green) are indicated. Only significant aberrations are
visualized. ERBB2 amplification on Chromosome 17 across 20 DCIS
samples is indicated. The aberration is localized to an approximately 1-
Mb region across the samples. The line graph on the right tracks the
confidence at each location, where regions of significant gain are
indicated in green and significant loss are indicated in red.
(B) Chromosome 8 across 20 DCIS samples. A large number of losses are
detected on the p arm as well as the centromeric side of the q arm, while
the telomeric end of the q arm contains many gains. These general
patterns are interrupted by gains on the p arm and losses on the q arm
that are detected with high confidence across multiple samples.
doi:10.1371/journal.pgen.0030143.g007
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Determining Conserved Genomic Aberrationsnonconcordant interval i in sample k, denoted wki, is
determined by wki ; Geometric(1/E[w]). The underlying
aberrations for a model containing four concordant aberra-
tions with varying nonconcordant aberrations are shown in
Figure 11B.
Simulated datasets. We generated datasets with a ﬁxed
copy number for both the concordant aberrations and the
background aberrations. We note that while real data
probably does not follow this assumption, for the sake of
testing, this assumption causes us to be more conservative.
This is because if the underlying copy number mean is higher
for concordant aberrations, then we are likely to pick them
up above the level of noise in our ﬁrst few tests. The
background noise would then be minimal and the concord-
ance would be evident from the overlap. However, by
modeling the copy number means as identical we expect to
have both concordant and nonconcordant intervals in all of
our tests because their underlying distributions are identical.
Datasets were generated simulating a single ‘‘chromosome
arm,’’ because permutations and test values are calculated for
each arm independently. We placed 50 markers representing
nonoverlapping regions of the arm. We randomly simulated
the widths of selected aberrations from one to ﬁve. The
underlying frequency of concordant aberrations varied from
50% to 75% of samples. The datasets were simulated with 50
samples each. The boundaries of concordant aberrations
were changed randomly by the placement of nonconcordant
intervals. We also ﬁxed the variance (r
2) for all datasets to r¼
1. We estimated the true variance within multiple datasets to
be approximately r ’ 0.2, which was the value used by Olshen
et al. [14]. We followed the model and parameter choices of
Lai et al. [12], so the results can be compared directly to their
multiple comparisons.
We generated a total of 700 simulated datasets and
estimated the true positive rate (TPR) and false discovery
rate (FDR) overall for all the experiments. The TPR
measures the number of known concordant regions that
were detected as concordant aberrations by our algorithm
divided by the total number of known concordant aberra-
tions (TPR ¼
Concordant regions found by MSA
All Concordant Regions ). The FDR is the
number of regions known to be nonconcordant that were
called concordant by our algorithm (false positives) divided
by the total number of predicted concordant aberrations by
the algorithm (FDR ¼
Nonconcordant regions called concordant by MSA
Regions called concordant by MSA ).
The signal-to-noise ratio (SNR) is deﬁned as the mean of the
segment distribution divided by the standard deviation of
the segment distribution (SNR ¼
l
r).
Simulation results. We simulated data based on the model
presented above. The performance of the MSA algorithm on
datasets with varying SNRs is shown in Figure 12A. We found
that as we increased the SNR, the sensitivity (true positive
rate for a given false discovery rate) increased. Furthermore,
we found that random noise does not signiﬁcantly affect the
results so long as the SNR is constant. As we increased the
nonconcordant noise, the sensitivity decreased; the perform-
ance for varying parameters is shown in Figure 12B. However,
despite increasing nonrandom noise, MSA still performs
consistently well. Additionally, the FDR and FWER are
controlled for all noise levels, and the speciﬁcity remains
high for reasonable FDRs (,0.05) (Table 1).
Similarly, we varied the copy number averages and
compared the affect on the speciﬁcity and sensitivity (FDR
versus TPR). MSA identiﬁed 99% true positives for less than
5% FDR for an SNR of 2. MSA also identiﬁed 80% true
positives for an FDR of less than 5% for an SNR of 1. These
results are based on simulations where the non-random noise
was varied from very low to very high (k¼0, ..., 60). If we ﬁx a
value of k and vary the noise parameters, we see that for
moderate noise parameters the accuracy and speciﬁcity of an
SNR of 1 becomes better. For k ¼ 5 we observe 87% true
positives for less than 5% FDR, and for k¼10 we observe 81%
true positives for less than 5% FDR. The speciﬁc values of the
TPR and FDR are provided for each value of a in table 1.
Comparison with single sample methods. An analysis of
single sample methods was performed by Lai et al. [12], and
receiver operating characteristic curves were plotted for
those methods. The single sample simulator used in this
manuscript follows the same model. The accuracy and
speciﬁcity of MSA as compared to the single sample methods
is apparent when comparing these results to Figure 2 of Lai et
al. [12]. While most single sample methods performed well
with high SNR, and large width of aberration, these methods
all perform signiﬁcantly worse for smaller SNR and widths.
Our true segments were simulated with widths 1, 2, and 3 for
the purposes of the characteristic curves. The ability to detect
smaller regions at lower SNR becomes apparent. At SNR ¼ 1
and width 5, the TPR of the best single sample method is
approximately 40% for a false positive rate of 5%, whereas
most methods fail to detect anything at all [12].
Finally, we are plotting the TPR versus the FDR rather than
the false positive rate. This is because the false positive rate is
not appropriate for assessing error rates in highly parallel
multiple testing problems where there are relatively few false
null hypotheses as compared to the total number of
hypotheses. The FDR is widely accepted as the appropriate
way to assess error rates in such situations. The more
conservative nature of the FDR for false results in the
prediction set makes us even more conﬁdent in the ability to
detect smaller aberrations at lower SNR ratios than the best
single sample method.
Observations. We found that large amounts of simulated
technical noise in the system (r
2) do not affect the results.
Rather, the overall SNR can dramatically change the results as
shown in ﬁgure 12b. Furthermore, we found that the amount
Figure 8. Comparison of Two Single Sample Methods on Chromosome 8 for DCIS
(A) DNAcopy (CBS) indicates gross level aberration. On most samples, CBS finds a large loss on the p arm and gain on the q arm. Additionally, on some
samples CBS finds a large deletion on the q arm near the centromere. The y-axis represents the log ratio of the sample, the x-axis represents the
genomic position, and the red lines represent the average copy number for each segment.
(B) ChARM similarly finds gross level aberration including loss of the p arm and gain of the q arm. (red, gain and green, loss). ChARM misses the
amplification of MYC in many samples, and in a few samples detects the amplification as a contiguous segment covering the entire q arm. The y-axis
represents the log2(T/R) ratio of the sample and the x-axis represents the genomic position of the probe. Red boxes signify significant gain segments,
green boxes signify significant loss segments, and the height of the bars represents the log ratio.
doi:10.1371/journal.pgen.0030143.g008
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Determining Conserved Genomic AberrationsFigure 9. MSA Analysis of Neuroblastoma Dataset for Chromosome 2
(A) The merged view combines results from all cutoff values used. In the merged view, only the concordant aberration has been retained. All noise and
nonconcordant signal has been filtered out for a clear visual representation of the concordant aberration and the contributing samples.
(B) Individual views indicate results for five of the MSA test values along with their significance at each value.
doi:10.1371/journal.pgen.0030143.g009
Figure 10. CBS Algorithm Combined with the MSA Approach
The CBS algorithm was applied to segment the data and MSA was run on the resulting segments to determine conserved aberrations. Various values of
the parameter for calculation of the segments were used. (A) represents the data of Mosse et al. on Chromosome 2 for the parameter value a¼0.05 and
applying MSA. (B) represents the data of Naylor et al. on Chromosome 17 for various values of the parameter (a) from 0.05 to no segmentation.
doi:10.1371/journal.pgen.0030143.g010
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Determining Conserved Genomic AberrationsFigure 11. Underlying Model of the Simulated Data
(A) Illustrates how concordant and nonconcordant aberrations are placed in the data. White circles represent locations containing no aberrations. Black
circles represent intervals of nonconcordant aberrations. Blue circles represent intervals of concordant aberrations. In the blue and black circles the
indicator random variable would have a value of 1 and the white circles would have a value of 0. The underlying frequency controls the expected
number of aberrant samples containing a given concordant aberration. All circles represent random variables with the noise distribution described in
the text.
(B) Shows the underlying model on real data. The technical noise is not shown; only aberration intervals placed in the data are shown. The blue boxes
highlight the placed concordant aberration regions. All the parameters for the different images were identical with the exception of the k parameter,
which was varied from k ¼ 0, ..., 50.
doi:10.1371/journal.pgen.0030143.g011
Figure 12. Simulated Data Accuracy Curves
Receiver operating characteristic–type curves are presented here as a measure of the accuracy of the MSA algorithm. The x-axis represents the FDR and
the y-axis represents the TPR for each dataset. The graph was generated by determining the TPR and FDR at selected a values. If p , a, then the region
is called significant, and if the region is known to be aberrant it is counted toward the TPR. If it is not aberrant, it is counted as a false positive. The
values of a from which the plot was generated are plotted and the general curve is overlaid.
(A) SNR is set equal to 1 for all comparison and the amount of nonconcordant signal is varied. Lambda is the mean nonconcordant signal in each profile.
As we raise the amount of nonconcordant noise, we reduce the ability to detect true signal.
(B) Lambda is fixed at a value of 10 and the SNR is varied to determine the effect of changing this parameter on detection of concordant aberrations. As
we decrease the SNR, it becomes harder to detect concordant aberrations. At a SNR¼2 we detect 100% true positives with almost no false positives.
doi:10.1371/journal.pgen.0030143.g012
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of concordant aberrations. However, even with large percen-
tages of the proﬁle distorted by nonconcordant aberrations it
is possible to detect most of the concordant aberrations
(Figure 12A).
Additionally, we found that the width of concordant
intervals did not affect the accuracy of the method. The
accuracy and speciﬁcity did not change for concordant
intervals of width 1, width 5, width 25, or width 100. However,
the ability to pick up smaller (width) aberrations at lower
underlying frequencies decreased as we increased the non-
concordant noise in the system. Additionally, we found that
the underlying frequency of aberration can change the
speciﬁcity dramatically and increase the effects of the other
variables. With high SNR we can detect aberrations with
lower underlying frequency. As we decrease the SNR, a higher
underlying frequency is needed to detect concordant
aberrations. Similarly, as the nonconcordant intervals in-
crease, the harder it becomes to detect smaller frequency
aberrations.
Additionally, the number of samples included in the
simulation model can affect whether we detect regions as
aberrant. As we increase the number of samples, it becomes
easier to detect concordant aberrations. The larger the
number of samples the more likely we are to detect lower
underlying frequency aberrations within a dataset. However,
very low frequencies become harder to detect regardless of
the number of samples. As we decrease the nonconcordant
noise, we can begin to detect smaller frequencies with greater
accuracy.
The length of the simulated genome can affect the results
detected. If we increase the size of the genome and keep the
number of aberrations and background the same, we ﬁnd that
speciﬁcity and accuracy increase. This result is not surprising,
as there are more possible arrangements of the null data and
the likelihood of overlap in the null model is smaller. This
increase in speciﬁcity and sensitivity seems to be the same
change that is observed with the increase in the number of
aberrations per model.
The width of aberrant intervals does not affect the
performance of the algorithm. The only effect seems to come
from the percentage of the genome that is aberrant, similar to
the effect of increasing the genome size. If we ﬁx all other
parameters, as we increase the width of intervals the
sensitivity decreases in a similar fashion. However, if we have
a larger genome size and wider aberrations, we see no
decrease in sensitivity.
In real data with high background aberration it is possible
to pick up low frequency events (,5%). However, in our
simulation model we found that the underlying frequency of
aberration can affect the results that are detected. For very
low frequency of aberration (,5%) it is hard to detect
concordant aberrations in our simulation model. If we
increase the SNR, there is a minimal increase in the
speciﬁcity and sensitivity. Similarly, if we decrease the
nonconcordant intervals or increase the number of samples,
there is a minimal increase. However, if we model the
concordant noise and nonconcordant noise with different
underlying means, we can begin to detect lower frequencies
with greater sensitivity and speciﬁcity. In reality, the means of
Table 1. Values of the TPR and FDR for the Cutoff Values Indicated
ak ¼ 5 k ¼ 10 k ¼ 20 k ¼ 35 k ¼ 50
FDR TPR FDR TPR FDR TPR FDR TPR FDR TPR
0.01 0.002309469 0.553846154 0 0.5 0 0.448717949 0 0.487179487 0 0.467948718
0.025 0.001834862 0.697435897 0.004106776 0.621794872 0.0041841 0.61025641 0 0.615384615 0 0.582051282
0.035 0.001686341 0.758974359 0.006968641 0.730769231 0.005703422 0.670512821 0.001897533 0.674358974 0 0.633333333
0.05 0.001615509 0.792307692 0.008291874 0.766666667 0.005328597 0.717948718 0.003629764 0.703846154 0.001890359 0.676923077
0.06 0.001592357 0.803846154 0.008210181 0.774358974 0.008665511 0.733333333 0.005338078 0.716666667 0.003663004 0.697435897
0.07 0.007656968 0.830769231 0.011217949 0.791025641 0.014705882 0.773076923 0.010380623 0.733333333 0.017605634 0.715384615
0.08 0.009104704 0.837179487 0.014218009 0.8 0.01458671 0.779487179 0.016835017 0.748717949 0.02417962 0.724358974
0.09 0.011816839 0.857692308 0.015432099 0.817948718 0.02685624 0.78974359 0.031045752 0.76025641 0.034653465 0.75
0.15 0.041608877 0.885897436 0.055865922 0.866666667 0.08913649 0.838461538 0.101573677 0.805128205 0.100995733 0.81025641
0.2 0.065159574 0.901282051 0.076 0.888461538 0.116580311 0.874358974 0.126514132 0.832051282 0.128686327 0.833333333
0.25 0.077220077 0.919230769 0.089147287 0.903846154 0.124528302 0.892307692 0.146907216 0.848717949 0.148854962 0.857692308
0.3 0.087231353 0.925641026 0.100253807 0.908974359 0.139194139 0.903846154 0.15875 0.862820513 0.157107232 0.866666667
0.35 0.101965602 0.937179487 0.116421569 0.924358974 0.150295858 0.920512821 0.173123487 0.875641026 0.167883212 0.876923077
0.4 0.107878788 0.943589744 0.120627262 0.934615385 0.159487776 0.925641026 0.177725118 0.88974359 0.175837321 0.883333333
0.45 0.110843373 0.946153846 0.132701422 0.938461538 0.169724771 0.928205128 0.18872267 0.903846154 0.184056272 0.892307692
0.5 0.125295508 0.948717949 0.146171694 0.943589744 0.176670442 0.932051282 0.202247191 0.91025641 0.190972222 0.896153846
0.55 0.134032634 0.952564103 0.156392694 0.947435897 0.185061315 0.937179487 0.211622807 0.921794872 0.197488584 0.901282051
0.6 0.140046296 0.952564103 0.162344983 0.952564103 0.191419142 0.942307692 0.221382289 0.924358974 0.204264871 0.908974359
0.65 0.145977011 0.952564103 0.172566372 0.958974359 0.196078431 0.946153846 0.232978723 0.924358974 0.211049724 0.915384615
0.7 0.147597254 0.955128205 0.179627601 0.96025641 0.201075269 0.952564103 0.235480465 0.928205128 0.218102508 0.919230769
0.75 0.154370034 0.955128205 0.18851571 0.96025641 0.203624733 0.957692308 0.239039666 0.934615385 0.226495726 0.928205128
0.8 0.158605174 0.958974359 0.191192266 0.965384615 0.210137276 0.958974359 0.243523316 0.935897436 0.231177094 0.929487179
0.85 0.168701443 0.96025641 0.197662062 0.967948718 0.213836478 0.961538462 0.246659815 0.93974359 0.233684211 0.933333333
0.9 0.171270718 0.961538462 0.2 0.969230769 0.216075157 0.962820513 0.250255363 0.941025641 0.237199582 0.935897436
0.95 0.176341731 0.964102564 0.203157895 0.970512821 0.222567288 0.962820513 0.255276382 0.95 0.244582043 0.938461538
The results are based on the simulated data where all parameters are fixed at l ¼ 1.0, k ¼ 10, and r ¼ 1.0, except where otherwise indicated.
doi:10.1371/journal.pgen.0030143.t001
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Determining Conserved Genomic Aberrationsconcordant and nonconcordant intervals are probably differ-
ent, although we do not have a biological understanding of
this difference to accurately model it. We note that this is a
potential explanation for our ability to detect low frequency
aberrations in real data.
Discussion
We demonstrate a powerful multiple sample approach for
the analysis of array-based comparative genomic hybrid-
ization data and illustrate the effectiveness of this method in
detecting known small regions of aberration at the native
resolution of the arrays, with high statistical conﬁdence.
Aside from the detection of known regions of aberration, we
have also identiﬁed many uncharacterized aberrations. The
power in the method relies on the use of liberal single sample
methods together with a permutation-based statistical test for
analysis of concordant genomic regions.
In theory, even if there is an ‘‘optimal’’ single sample cutoff
value for making aberration calls, there may still be conserved
regions of aberration that are not detected. Even though at
lower levels there may be more noise in the data, we are not
more likely to pick up false signals because STAC accounts for
the higher rate of random aberration. While MSA approaches
the problem of determining interesting regions across multi-
ple samples rather than within a sample, we can use the results
of MSA analysis to determine the singe sample values for each
experiment. This also acts as a valuable visual aid.
Biological Motivation
The method presented in this manuscript assesses the
signiﬁcance of these aberrations as characteristics of a
deﬁned class of samples. This is done by looking at each
location of the genome and determining the probability of
the concordance occurring across the samples, as compared
to the background rate of aberration. This reveals regions
that are conserved due to a nonrandom pressure as compared
to the background rate of genomic aberration. Therefore, if a
genomic aberration does not contribute to the overall ﬁtness
of the cancer, it is unlikely to be conserved across samples at a
rate greater than the random rate of aberrations in the
samples. In this way, the method attempts to model a known
biological phenomenon in a robust statistical manner.
Interpreting the Results
MSA provides adjusted p-values for signiﬁcance of aberra-
tion. The null hypothesis we are testing is the absence of
concordant genomic aberration at position X. Therefore a
signiﬁcant result indicates that there is evidence for
concordant aberrations at position X. This is not to say that
there are no aberrations at nonsigniﬁcant locations, but
rather that there is no signiﬁcant concordant aberration. This
is in contrast to segmentation, or single sample methods,
described earlier. In reality, an aberration may be quite large,
while the concordant part of the aberration is small.
Therefore, one must not consider an MSA region of gain or
loss indicated in a sample as representing the total length of
the aberration in the sample. Our method aims to identify
only the conserved segment of this aberration.
MSA can detect conserved heterogeneity within a subgroup
as small as two samples. This can be seen in some of the
results provided in this manuscript. However, our method
does not always detect such subtle effects; the exact results
depend on the rate of aberration in the genome. If there is
little noise, then two samples can contribute to a signiﬁcant
result; however, if there is a lot of noise the same result may
Table 1. Extended.
al ¼ 0.7 l ¼ 0.8 l ¼ 1.0 l ¼ 1.1 l ¼ 1.2
FDR TPR FDR TPR FDR TPR FDR TPR FDR TPR
0.01 0 0.15 0 0.306410256 0 0.5 0 0.623076923 0 0.724358974
0.025 0 0.251282051 0.003154574 0.405128205 0.004106776 0.621794872 0.001709402 0.748717949 0 0.857692308
0.035 0.007874016 0.323076923 0.002695418 0.474358974 0.006968641 0.730769231 0.004658385 0.821794872 0.005681818 0.897435897
0.05 0.006802721 0.374358974 0.002512563 0.508974359 0.008291874 0.766666667 0.005970149 0.853846154 0.005540166 0.920512821
0.06 0.006472492 0.393589744 0.002427184 0.526923077 0.008210181 0.774358974 0.005899705 0.864102564 0.006868132 0.926923077
0.07 0.008902077 0.428205128 0.006849315 0.557692308 0.011217949 0.791025641 0.007267442 0.875641026 0.013404826 0.943589744
0.08 0.017045455 0.443589744 0.006772009 0.564102564 0.014218009 0.8 0.011494253 0.882051282 0.023715415 0.95
0.09 0.029177719 0.469230769 0.008733624 0.582051282 0.015432099 0.817948718 0.021156559 0.88974359 0.026143791 0.955128205
0.15 0.069196429 0.534615385 0.046728972 0.653846154 0.055865922 0.866666667 0.067620286 0.919230769 0.085234094 0.976923077
0.2 0.085953878 0.558974359 0.075471698 0.691025641 0.076 0.888461538 0.104878049 0.941025641 0.113557358 0.980769231
0.25 0.092843327 0.601282051 0.087947883 0.717948718 0.089147287 0.903846154 0.114695341 0.95 0.125284738 0.984615385
0.3 0.099065421 0.617948718 0.098901099 0.735897436 0.100253807 0.908974359 0.123529412 0.955128205 0.138857783 0.985897436
0.35 0.113274336 0.642307692 0.102134146 0.755128205 0.116421569 0.924358974 0.132097335 0.96025641 0.154015402 0.985897436
0.4 0.116838488 0.658974359 0.109955423 0.767948718 0.120627262 0.934615385 0.136624569 0.964102564 0.16468039 0.988461538
0.45 0.128455285 0.687179487 0.121212121 0.780769231 0.132701422 0.938461538 0.146561443 0.970512821 0.173959445 0.992307692
0.5 0.131955485 0.7 0.130496454 0.785897436 0.146171694 0.943589744 0.153072626 0.971794872 0.183544304 0.992307692
0.55 0.145061728 0.71025641 0.1375 0.796153846 0.156392694 0.947435897 0.162072767 0.974358974 0.189132706 0.994871795
0.6 0.149546828 0.721794872 0.139310345 0.8 0.162344983 0.952564103 0.167579409 0.974358974 0.194184839 0.994871795
0.65 0.156891496 0.737179487 0.145183175 0.807692308 0.172566372 0.958974359 0.175324675 0.976923077 0.2 0.994871795
0.7 0.164244186 0.737179487 0.148793566 0.814102564 0.179627601 0.96025641 0.1783029 0.980769231 0.203285421 0.994871795
0.75 0.171919771 0.741025641 0.156578947 0.821794872 0.18851571 0.96025641 0.181818182 0.980769231 0.205731832 0.994871795
0.8 0.175637394 0.746153846 0.159947984 0.828205128 0.191192266 0.965384615 0.184434968 0.980769231 0.212765957 0.996153846
0.85 0.179166667 0.757692308 0.168367347 0.835897436 0.197662062 0.967948718 0.19047619 0.980769231 0.218090452 0.997435897
0.9 0.184065934 0.761538462 0.170670038 0.841025641 0.2 0.969230769 0.197905759 0.982051282 0.222 0.997435897
0.95 0.1875 0.766666667 0.17625 0.844871795 0.203157895 0.970512821 0.202492212 0.984615385 0.231225296 0.997435897
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missed.
Finally, when running MSA on a chromosome arm, it may
fail to identify very large aberrations such as whole
chromosome gains and losses. This is because MSA looks
for signiﬁcant localized concordance. The less local, the more
samples might be needed to see the effect, while whole arm
gains and losses will not be seen in any case, when running a
single arm analysis. If one is interested in gross effects such as
whole arm gains and losses, MSA can be run at the whole
genome level.
Generalizations
The method is presented as a two-channel array applica-
tion with examples speciﬁcally from two-channel data.
However, the method generalizes to one-channel datasets.
The only difference is the methods used to determine single
sample values and relative copy number aberrations without
a reference ratio. In the two-channel case there is a clear gain
versus loss distinction (log2
Test Channel
Reference Channel ¼ 0); however, in
the case of one-channel data this is not the case. There are
multiple ways of avoiding this issue. If one has paired normal
samples, we can form log ratios based on the test hybrid-
ization and the paired normal hybridization such that the log
ratio is deﬁned as log2
Test Sample
Paired Normal. Alternatively, if one does
not have paired samples, then a standard denominator based
on a pool of normal hybridizations can be used to form log
ratios.
Furthermore, we are working on extending our algorithm
to detect regions of concordant loss of heterozygosity in SNP
microarray data. We believe this will be a simple extension to
our current approach with some modiﬁcations necessary for
calculating the probabilities of loss of heterozygosity at a
given position on the genome.
We have illustrated the use of MSA as a method for
determining regions of conserved aberration in cancer
genomes. However, this method can be used for other
questions, including determining concordant copy number
variations in the genome. So long as the question of interest is
a multiple sample question, such as, what are the regions that
contain more copy number polymorphisms than would be
expected by chance? We believe the method generalizes to
many areas where the underlying null model accurately tests
the question of interest.
Conclusions
We have shown the effectiveness of the MSA methodology
on several datasets, each of which helps demonstrate different
strengths of the method. First, we have demonstrated the
ability to identify meaningful biological information that
most current methods either miss entirely or mischaracterize.
Second, we have demonstrated the ability of our method to
distinguish between signal and noise within an extremely
noisy, but important, sample resource (FFPE tissue). Third, we
have demonstrated the increased power of our method over
the use of a single cutoff value. Finally, we have demonstrated
the ability to detect regions of aberration at high resolution.
The promise of aCGH is the ability to detect copy number
aberrations with accuracy and high resolution. MSA allows
for the detection of signiﬁcant regions of aberration in a
statistically signiﬁcant manner at high resolution. MSA allows
for the determination of conserved aberrations across a class
of samples, which is important to accurately proﬁle cancer
and other diseases. Finally, MSA results can be useful for
Table 1. Extended.
al ¼ 1.3 l ¼ 1.5 l ¼ 2.0
FDR TPR FDR TPR FDR TPR
0.01 0.001633987 0.783333333 0 0.9 0.001335113 0.958974359
0.025 0.00286944 0.891025641 0.001336898 0.957692308 0.002570694 0.994871795
0.035 0.004126547 0.928205128 0.003926702 0.975641026 0.003831418 1
0.05 0.004081633 0.938461538 0.006485084 0.982051282 0.010152284 1
0.06 0.006756757 0.942307692 0.011583012 0.984615385 0.022556391 1
0.07 0.006702413 0.95 0.024050633 0.988461538 0.049939099 1
0.08 0.013262599 0.953846154 0.028967254 0.988461538 0.065868263 1
0.09 0.020887728 0.961538462 0.058608059 0.988461538 0.090909091 1
0.15 0.091346154 0.969230769 0.118451025 0.992307692 0.162191192 1
0.2 0.124423963 0.974358974 0.158179848 0.996153846 0.184100418 1
0.25 0.140291807 0.982051282 0.169690502 0.997435897 0.2 1
0.3 0.149501661 0.984615385 0.179324895 0.997435897 0.220779221 1
0.35 0.166847237 0.985897436 0.195449845 0.997435897 0.230769231 1
0.4 0.171336207 0.985897436 0.206122449 0.997435897 0.23902439 1
0.45 0.178533475 0.991025641 0.218875502 0.997435897 0.246376812 1
0.5 0.182297155 0.994871795 0.226640159 0.997435897 0.25 1
0.55 0.189132706 0.994871795 0.232741617 0.997435897 0.258555133 1
0.6 0.19731405 0.996153846 0.237022527 0.998717949 0.264844486 1
0.65 0.204708291 0.996153846 0.242217899 0.998717949 0.270346118 1
0.7 0.210365854 0.996153846 0.24442289 0.998717949 0.279112754 1
0.75 0.215943491 0.996153846 0.2487946 0.998717949 0.285714286 1
0.8 0.223 0.996153846 0.250240616 0.998717949 0.290263876 1
0.85 0.227634195 0.996153846 0.256679389 0.998717949 0.294755877 1
0.9 0.229930624 0.996153846 0.261611374 0.998717949 0.297297297 1
0.95 0.23523622 0.996153846 0.262759924 1 0.301075269 1
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Determining Conserved Genomic Aberrationsclassifying samples, testing association between regions and
tumor types, and testing for various class prediction variables.
Materials and Methods
Array and data extraction. We created our 6,912-probe microarray
using a human BAC clone set spaced at 1-Mb intervals throughout the
genome [33]. We hybridized our samples to the array, where the
reference channel consisted of a pool of degenerate oligonucleotide–
primed PCR ampliﬁcation products from a commercial DNA source.
Aliquots of labeled target and reference DNA were cohybridized to
each BAC microarray with 100 lg of human Cot-1 DNA (Invitrogen,
http://www.invitrogen.com) to block repetitive sequences. The arrays,
in Corning Hybridization chambers (http://www.corning.com), were
incubated at 37 8C for 72 h, then washed, dried, and scanned with the
GenePix Microarrray Scanner (Axon Instruments, http://www.
moleculardevices.com). Data was extracted using the GenePix Pro
Software package.
Sample isolation. A skilled histotechnologist cut and mounted
single 10-lm thick parafﬁn sections of each target tissue onto PET-
membrane slides used with the SL lCUT System (Molecular Machines
& Industries, http://www.molecular-machines.com). Using conven-
tional methods, we deparafﬁnized, rehydrated and stained the
sections with hematoxylin. Within 1–2 h, we placed each section
into a microdissection unit that sandwiches the tissue section
between a clean glass slide and the membrane and microdissected
it with the SL lCUT System. This precision microdissection gave us
near-pure populations of LCIS and DCIS cells for whole genome
scanning.
Data normalization. We observed an intensity dependent bias and
performed print tip–speciﬁc loess normalization within each array
[22]. The normal samples were similarly normalized. We did not
perform scale normalization, as the distributions between the
samples were comparable to each other. We used the standard
deviation scheme for making gain/loss calls as described earlier.
Normal–normal distribution. We generated a distribution based on
23 normal mammary samples. We identiﬁed normal mammary tissue
that has been previously formalin ﬁxed and parafﬁn embedded and
subsequently laser capture microdissected normal cells. DNA was
subsequently extracted, labeled with Cy3, and hybridized to our array.
Our Cy5 channel contained identical pooled genomic DNA as our
sample hybridizations to allow for direct comparison.
Published neuroblastoma data. Previously published neuroblasto-
ma data [31] was used to test our method. The raw data was
downloaded from http://acgh.afcri.upenn.edu/nbacgh. Regions were
extended and genome spacing was standardized prior to analysis
using MSA. STAC analysis was conducted using the threshold
parameters provided by Mosse et al. [31], Gain 1.2 and Loss 0.8.
Genomic mapping. For comparative purposes, all genome coor-
dinates are based on Build 34 (Hg16 July 2003 Freeze) of the human
genome.
Published T cell leukemia SNP data. Previously published T cell
leukemia SNP data [30] was used to test our method. The raw data
(CEL ﬁles) were downloaded from http://www.stjuderesearch.org/data/
ALL-SNP1/ and are accessible from the Gene Expression Omnibus
(GEO). The data was preprocessed and normalized using the
GenePattern (http://www.broad.mit.edu/cancer/software/genepattern/)
[34] modules SNPFileCreator and CopyNumberDivideByNormals
[35]. The output ﬁle was fed directly into the MSA software package.
MSA algorithm and simulation model implementations. The MSA
algorithm and the Simulation model are implemented as stand-alone
java applications and are available along with documentation and
technical speciﬁcations at http://www.cbil.upenn.edu/MSA. STAC v1.2
is incorporated into the MSA algorithm and is also available as a
stand-alone java GUI application at http://www.cbil.upenn.edu/STAC.
Supporting Information
Figure S1. DNAcopy (CBS) Results for Six DCIS Samples on
Chromosome 17
CBS characterizes the Erbb2 ampliﬁcation at a gross level over half
the chromosome length. This ampliﬁcation can be more ﬁnely
localized to a 1–2-Mb region by MSA (see Figure 3).
doi:10.1371/journal.pgen.0030143.sg001 (749 KB PDF).
Figure S2. Frequency Plot of Signiﬁcant Aberrations in DCIS Samples
For all regions of signiﬁcance (p , 0.05) a frequency of aberration
was calculated and is plotted alongside the chromosome ideogram.
Green represents regions of signiﬁcant gain and red represents
signiﬁcant loss. The width of the bar represents the length of the
aberration and the height represents the frequency of aberration.
The tick marks represent 25%, 50%, 75%, and 100% frequency,
respectively.
doi:10.1371/journal.pgen.0030143.sg002 (2.2 MB PDF).
Figure S3. MSA Analysis of Chromosome 16 for LCIS
The ability to map aberrations at high resolution allows detection of
boundaries at the resolution of the array for known but broad copy
number differences on Chr16 previously identiﬁed by metaphase
CGH including high resolution detection of CDH1.
doi:10.1371/journal.pgen.0030143.sg003 (909 KB PDF).
Figure S4. Frequency Plot of Signiﬁcant Aberrations in LCIS Samples
For all regions of signiﬁcance (p , 0.05), a frequency of aberration
was calculated and is plotted alongside the chromosome ideogram.
Green represents regions of signiﬁcant gain and red represents
signiﬁcant loss. The width of the bar represents the length of the
aberration and the height represents the frequency of aberration.
The tick marks represent 25%, 50%, 75%, and 100% frequency,
respectively.
doi:10.1371/journal.pgen.0030143.sg004 (2.5 MB PDF).
Figure S5. Frequency Plot of Signiﬁcant Aberrations in Neuro-
blastoma Samples
For all regions of signiﬁcance (p , 0.05), a frequency of aberration
was calculated and are plotted alongside the chromosome ideogram.
Green represents regions of signiﬁcant gain and red represents
signiﬁcant loss. The width of the bar represents the length of the
aberration and the height represents the frequency of aberration.
The tick marks represent 25%, 50%, 75%, and 100% frequency,
respectively.
doi:10.1371/journal.pgen.0030143.sg005 (2.3 MB PDF).
Figure S6. Results of the MSA Algorithm Run on T-ALL SNP Data
[30]
A p-value plot of signiﬁcant regions identiﬁed by MSA in the T-ALL
SNP data. The dotted line on the right represent the signiﬁcance level
(p , 0.05) for gain, the left represents the signiﬁcance level for loss.
The results are plotted at a 100-kb resolution.
doi:10.1371/journal.pgen.0030143.sg006 (5.1 MB PDF).
Figure S7. Results of Single Sample Method Followed by MSA
Analysis Applied to T-ALL Data Proﬁled on a 250K SNP Array
A p-value plot of signiﬁcant regions identiﬁed by MSA in the
segmented T-ALL SNP data. The dotted line on the right represent
the signiﬁcance level (p , 0.05) for gain, the left represents the
signiﬁcance level for loss. The results are plotted at 100kb resolution.
doi:10.1371/journal.pgen.0030143.sg007 (4.7 MB PDF).
Table S1. MSA Signiﬁcant Regions Detected in Neuroblastoma
Dataset Published by Mosse et al. [31]
Regions listed are all regions that were detected by MSA with
corrected p-value , 0.05. Genomic coordinates are based on the build
16 of the human genome (hg16) based on the same data previously
reported by Mosse et al. and Diskin et al. All genomic regions
containing coverage, with the exception of clones on Chromosome Y,
were included in the analysis.
doi:10.1371/journal.pgen.0030143.st001 (79 KB XLS).
Table S2. MSA Signiﬁcant Regions Not Present in a STAC Analysis of
the Neuroblastoma Data
MSA p-values are compared to STAC p-values at these positions. MSA
was able to characterize 486 regions not detected by STAC alone.
doi:10.1371/journal.pgen.0030143.st002 (63 KB XLS).
Accession Numbers
The normalized and raw data (GPR ﬁles) generated in this study are
accessible from the National Center for Biotechnology Information
(NCBI) Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/
geo/), through accession number GSE8601. The previously published
T Cell Leukemia raw data (CEL ﬁles) is accessible at GEO through
accession number GSE5511.
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